E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases
Open Access
- 1 January 2010
- journal article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 14 (1-2), 381-391
- https://doi.org/10.1111/j.1582-4934.2008.00548.x
Abstract
E10A, a replication‐defective adenovirus carrying human endostatin gene, has finished Phase I clinical trials for solid cancers. We assessed whether the combination of E10A with docetaxel would enhance antiangiogenic activities and inhibit prostate cancer growth and metastases. Combination use of conditioned medium from prostate cancer cells infected by E10A and docetaxel exerted synergistic inhibition of HUVECs proliferation, migration and tube formation, compared with either agent alone. In prostate cancer s.c. xenograft models, combined therapy resulted in significant tumour growth inhibition and survival improvement. The antitumoural effect was tightly correlated with a remarkable decrease in tumour cell proliferation, microvessel, especially immature vasculature and significant increase in apoptosis induction. Systemic administration of E10A and docetaxel also effectively inhibited orthotopic growth and metastases of prostate cancer and achieved better in vivo antiangiogenic effects than either agent alone. Our data indicate that E10A in combination with docetaxel exert enhanced antiangiogenic activities and inhibit prostate cancer growth and metastases. Therefore, this approach may be an effective treatment for advanced prostate cancer and deserves more extensive investigation.Keywords
This publication has 46 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumorsGene Therapy, 2007
- Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hopeJournal of Cellular and Molecular Medicine, 2007
- Long-Term Toxicity Studies in Canine of E10A, An Adenoviral Vector for Human Endostatin GeneHuman Gene Therapy, 2007
- Minicircle-IFNγ Induces Antiproliferative and Antitumoral Effects in Human Nasopharyngeal CarcinomaClinical Cancer Research, 2006
- Gene Transfer of Kringle 1–5 Suppresses Tumor Development and Improves Prognosis of Mice With Hepatocellular CarcinomaGastroenterology, 2006
- Adenovirus‐mediated intra‐tumoral delivery of the human endostatin gene inhibits tumor growth in nasopharyngeal carcinomaInternational Journal of Cancer, 2005
- Improved Therapeutic Effectiveness by Combining Recombinant CXC Chemokine Ligand 10 with Cisplatin in Solid TumorsClinical Cancer Research, 2005
- Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinasesCancer Cell, 2004
- The anti-angiogenic basis of metronomic chemotherapyNature Reviews Cancer, 2004